Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • September 14 2023

    Ampio Pharmaceuticals, Inc. announced the commencement of its At The Market Offering in the amount of $1,250,000.  EG&S acted as counsel to the Sales Agent.

  • September 13 2023

    Paul Rooney, a member of the Firm, wrote an article for Total Food Service titled: “Legal Fall Cleaning: 4 Areas To Shore Up Your Compliance And Stay Clean.”

    Click here to read the article.

  • September 13 2023

    AgileAlgo Holdings Limited, a British Virgin Islands business company that, through its Singapore-based subsidiary, AgileAlgo Pte Ltd., is a maker of enterprise-grade natural language code generator for machine-learning and data management platforms and Inception Growth Acquisition Limited, a Delaware incorporated publicly traded special purpose acquisition company, announced they have entered into a definitive agreement for a business combination. Upon closing of the business combination, the combined company will be organized in the British Virgin Islands and renamed “Prodigy, Inc.” and expects to list its ordinary shares on Nasdaq under the ticker symbol “PRGY.” EGS is serving as legal advisor to AgileAlgo Holdings Limited.

  • September 12 2023

    Aditxt, Inc. announced the closing of its Private Placement Offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.

  • September 12 2023

    Digital Brands Group, Inc. announced the closing of its Private Placement Offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.

  • September 12 2023

    David R. Rothfeld, a member of the Firm, was a panelist on the 21st Annual Labor & Employment Law Roundtable held on September 11, 2023 at the Cornell Center for Innovative Hospitality Labor & Employment Relations.

  • September 09 2023

    Blue Star Foods Corp. announced the closing of its Public Offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.

  • September 08 2023

    Cellectar Biosciences, Inc. announced the closing of its Private Placement Offering in the amount of $103,000,000. EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”